Sort

Search

01/03/2024 Is there a role for Bacillus Calmette-Guerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics
Henriquez, JDS, Krajewski, W, González-Padilla, D, Taborda, J, Andrzej, T, Aumatell, JL, Rodrigo, E, Moschini, M, Cano-Velasco, J, Gallioli, A, D Andrea, D, Pilcher, R, Afferi, L, Del Giudice, F, Albisinni, S, Soria, F, Laura, M, Szydelko, T, Burgos, JB, Gonzalez, AS, Medina, AA, Dos Santos, VG, Cidre, MNJ, Revilla, FJB. Is there a role for Bacillus Calmette-Guerin in very high-risk non-muscle invasive bladder carcinoma? Multicenter analysis of oncological outcomes and risk dynamics. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2024 Oncologic outcomes of endoscopic management of upper tract urothelial carcinoma: A systematic review and pooled analysis from the EAU-YAU Urothelial Working Group
Gallioli, A, Uleri, A, Mertens, L, Tedde, A, Moschini, M, Del Giudie, F, Soria, F, Laukhtina, E, Daniel, SJ, Krajewski, W, D'Andrea, D, Mari, A, Marcq, G, Mori, K, Teoh, J, Afferi, L, Basile, G, Territo, A, Sanguedolce, F, Breda, A, Pradere, B. Oncologic outcomes of endoscopic management of upper tract urothelial carcinoma: A systematic review and pooled analysis from the EAU-YAU Urothelial Working Group. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2024 Perioperative surgical complications in robot-assisted vs. pure laparoscopic living donor nephrectomy: A European Robotic Urology Section (ERUS) RAKT working group study
Campi, R, Pecoraro, A, Gallioli, A, Territo, A, Basile, G, Berlin, C, Etcheverry, B, Musquera, M, Vangeneugden, J, Orteved, M, Zeuschner, P, Volpe, A, Garcia-Baquero, R, Kocak, B, Idu, M, Fornara, P, Rohrsted, M, Alcaraz, A, Doumerc, N, Vigues, F, Decaestecker, K, Serni, S, Breda, A. Perioperative surgical complications in robot-assisted vs. pure laparoscopic living donor nephrectomy: A European Robotic Urology Section (ERUS) RAKT working group study. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).
01/03/2024 Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer
Contieri, R, Beijert,, Martini, A, Camperat, EM, Hernandez,, Bruins, HM, Dominguez-Escrig, JL, Liedberg, F, Masson-Lecomte, A, Cohen, D, Mostafid, H, Shariat, SF, Roupret, M, Pradere, B, Zigeuner, R, Soria, F, Soukup,, Redorta, JP, Capoun, O, Burger, M, Gontero, P, Sylvester, R, Mertens, L, Van Rhijn, BWG. Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer. EUROPEAN UROLOGY. 2024; 85DOI:. PMID:. IF:25.200(Q1/1D).